Trans Genic Group Inc. · TSE:2342

Trans Genic — FY2015 Earnings Presentation

38 slides from Trans Genic's earnings presentation, May 25, 2016

1. Slide 1: KWWSZZZWUDQVJHQLFFRMS

   ফা਋ ৠ઴ହ৥ভ ‫ع‬য‫ر‬भ௏೨ध௹ऊऩථैखभञीप‫ع‬ KWWSZZZWUDQVJHQLFFRMS ফ‫ڱ‬া঩ ઙૄভ঺ॺছথ५४ख़ॽॵॡ ି‫؟‬ਊৱમप੶ൗऔोञ৔ઍम‫ؚ‬ਠৎਡपउःथ঳ಹ৓पੳ௙औोथःॊ৽ੋ‫঺؞‬ভಉभੲિउेलਊ঺ऋ়৶৓धਖ਼૵खञ৽੾ੑ઺प੦तऌ ੿ਛखथउॉऽघऋ‫੾৽ؚ‬୭୆भ૗৲ಉभহ૓पेॉ‫ؚ‬੒ઔऩखप૗ಌऔोॊ૭ચਙऋँॉऽघ‫؛‬ऽञ‫ؚ‬০৏भਊ঺भ৽੾ਛౚ఺लଃ৆૾ ଙपणऌऽखथम‫ؚ‬৘ৃभ৿਱‫ؚ‬ৗૼ୒भ৫৅఺ल଼়౎঺भ૾யಉपेॉ‫ؚ‬পऌऎ૗৿घॊ૭ચਙऋँॉऽघ‫؛‬

2. Slide 2: Table of Contents

   7DEOHRI&RQWHQWV ৯ ઃ ⋛ফা਋৴੥ৠ઴໪ਏ ⋜ফা਋৴੥঵ౚ੒୳ ⋝হ঵ॺআॵॡ५ ⋞ଢ଼஢৫৅૾ய ⋟ॺআॵॡ५ Copyright© TransGenic Inc. All Rights Reserved. 2

3. Slide 3: Overview of consolidated financial results

   ⋛ফা਋৴੥ৠ઴໪ਏ Copyright© TransGenic Inc. All Rights Reserved. 3

4. Slide 4: Overview of Consolidated Financial Results

   2YHUYLHZRI&RQVROLGDWHG)LQDQFLDO5HVXOWV ফা਋৴੥ৠ઴‫ঁ؟‬ॖছॖॺ ਂ఼઴হ঵఺लਅറ৓਺ৱ॑ลઽखऩऋै਋৴ਢహஊ॑୸ਛ ¾ ৐ফૻ٫भੜઽ‫؛‬াभ'7&হ঵௤ଷ॑ลઽख੾঵ਹஇੜஇ ¾ ਅറ৓਺ৱ‫੅ق‬ী১௤ଷ‫఺ك‬लৱস৹୸ા৷॑ลઽख৽ଞਹஇੜஇ ౐ਜ਼‫૸؟‬৞ ফা਋ ফা਋ ੜ੖પ ਲ਼঱ৈ ਲ਼঱ਉ੼ ਲ਼঱੕ਹஇ ୿ଵા ‫ٻ‬ ‫ق‬ଢ଼஢৫৅ા‫ك‬ ‫ ق‬ ‫كق‬ ‫كق‬ ੾঵ਹஇ ৽ଞਹஇ ஡ভ঺ઙ਌पషര घॊਊ਋ෞਹஇ ‫ٻ‬ Copyright© TransGenic Inc. All Rights Reserved.

5. Slide 5: Overview of Consolidated Financial Results: Sales

   2YHUYLHZRI&RQVROLGDWHG)LQDQFLDO5HVXOWV ফা਋৴੥ৠ઴‫؟‬ਲ਼঱ৈ ਲ਼঱ৈ ૌு‫گ‬਋৑௓୎ ‫ق‬௲ਐ৞‫ك‬ ਲ਼঱ਛশ૨Ń ŔřőŜ٫Ń &52হ঵஀৹ Copyright© TransGenic Inc. All Rights Reserved. 5

6. Slide 6: Overview of Consolidated Financial Results: Operating Income

   2YHUYLHZRI&RQVROLGDWHG)LQDQFLDO5HVXOWV ফা਋৴੥ৠ઴‫੾؟‬঵ਹஇ ੾঵ਹஇ ‫ق‬௲ਐ৞‫ك‬ ૌு‫گ‬਋৑௓୎ ৐਋ૻŃ ŔŔŕőś٫ੜŃ ŧŷŦহ঵௤ลઽŃ ‫ٻ‬ Copyright© TransGenic Inc. All Rights Reserved. 6

7. Slide 7: Overview of Consolidated Financial Results: Ordinary Income

   2YHUYLHZRI&RQVROLGDWHG)LQDQFLDO5HVXOWV ফা਋৴੥ৠ઴‫੾؟‬঵य़কॵ३গ‫؞‬ইট‫ش‬ ੾঵य़কॵ३গ‫؞‬ইট‫ش‬ ૌு‫گ‬਋৑௓୎ ‫ق‬௲ਐ৞‫ك‬ ৐਋ૻ೅ੜŃ ŔŔŔőŚňੜŃ ਭିੜਸपൣअŃ ీ৺৐ਭসੜਸŃ Copyright© TransGenic Inc. All Rights Reserved. 7

8. Slide 8: Overview of Sales Revenue: Genomics Business

   2YHUYLHZRI6DOHV5HYHQXHt*HQRPLFV%XVLQHVV ७ॢওথॺશ঵ౚ໪ਏ‫؟‬४ख़ঀ঑ॡ५হ঵ ४ख़ঀ঑ॡ५হ঵ ঵ ¾ ਭ౏‫ق‬ಿ৬হ঵‫ك‬ਲ਼঱ऋ৐਋ૻद଩ഊ ਭ౏‫ق‬ಿ৬হ঵‫ك‬ਲ਼঱ऋ৐਋ૻद଩ഊ ਭ౏‫ق‬ಿ৬হ঵‫ك‬ਲ਼ ਲ਼঱ऋ ৐਋ૻ ৐਋ૻ‫ؚ‬ੑ઺ૻ ੑ઺ૻ ਹஇ૨ऋৈःহ঵भञीਲ਼঱੖ऋਹஇ੖पઉ੥ ¾ ୰ଙ૭ଳ৲ঐक़५‫'ؚ‬HOWDJHQ঺ঐक़५ಉঔॹঝঐक़५୿ਲ਼पିৡ ਲ਼঱ৈ ੾঵ਹஇ ૸৞ ૸৞ 70,000 60,000 50,000 40,000 30,000 20,000 10,000 0 2015 2016 Copyright

9. Slide 9: Overview of Sales Revenue: Contract Research Organization Business

   2YHUYLHZRI6DOHV5HYHQXHt&RQWUDFW5HVHDUFK2UJDQL]DWLRQ%XVLQHVV ७ॢওথॺશ঵ౚ໪ਏ‫&؟‬52হ঵ &52 2হ঵ ঵ ¾ ಏ෫‫ؚ‬శಏ෫૥ୡ৸ಹपॎञॉਭିඃ੭ऋ஀৹प௓୎‫ق‬৐਋ૻ٫‫ك‬ ಏ ಏ෫ శಏ෫૥ୡ৸ಹपॎञॉਭିඃ੭ऋ஀৹प௓୎‫ق‬৐਋ૻ ٫‫ك‬ శ శಏ෫ ख‫ؚ‬ਲ਼঱ৈপ்ੜઽ‫ق‬৐਋ૻ‫ك‬ য౫‫ؚ‬ਝ૟਺ৱ॑ลઽखथপ்ੜઽੜஇ ¾ ਬऌਢऌॢঝ‫ش‬উ૚হ঵धभ৴௚ਘ৲‫ؚ‬ৗૠઽஇঔॹঝभનয়धਹஇఁপ ਲ਼঱ৈ ੾঵ਹஇ ૸৞ ৞ ૸৞ Copyright© TransGenic Inc. Al

10. Slide 10: Overview of Sales Revenue: Advanced Medical Business

    2YHUYLHZRI6DOHV5HYHQXHt$GYDQFHGPHGLFDOEXVLQHVV ७ॢওথॺશ঵ౚ໪ਏ‫؟‬੔ഈୢ௜হ঵ ੔ഈୢ௜হ঵ ঵ ¾ ఩஫৕ੰෲਭ౏‫ؚ‬ী৕୰৶ਭ౏஀৹पेॉੜઽ ৐਋ૻ াাभ'7&হ঵ਂஷपेॉੜઽऩॊु੖இ ¾ ਛশী৙धਜ਼઼હऐॊী৕୰৶ਭ౏१‫ش‬অ५भ੾঵‫؞‬ਭିपିৡ ਲ਼঱ৈ ੾঵ਹஇ ૸৞ ૸৞ Copyright© TransGenic Inc. All Rights Reserved. 10

11. Slide 11: Overview of Sales Revenue: Pathological Diagnostics Business

    2YHUYLHZRI6DOHV5HYHQXHt3DWKRORJLFDOGLDJQRVWLFVEXVLQHVV ७ॢওথॺશ঵ౚ໪ਏ‫؟‬୰৶൧૵হ঵ ୰৶൧૵হ঵ ঵ ¾ ਲ਼঱ৈम‫ؚ‬ದ৹प௓୎खੜઽ‫؞‬ੜஇ ७থॱ‫ش‬ઈ੾஍૨৲भ੥ટ‫ؚ‬ਲ਼঱ੜऋਹஇੜपઉ੥ ¾ ৗૠ१‫ش‬অ५‫ق‬ঽഞ఼਄+39‫ك‬भমત৫઩पेॊઽஇఁপ॑௕ॊ ਲ਼঱ৈ ੾঵ਹஇ ૸৞ ૸৞ Copyright© TransGenic Inc. All Rights Reserved. 11

12. Slide 12: Consolidated business forecast

    ⋜ফা਋৴੥঵ౚ੒୳ Copyright© TransGenic Inc. All Rights Reserved. 12

13. Slide 13: Consolidated Business Forecast for the Year Ending March

    &RQVROLGDWHG%XVLQHVV)RUHFDVWIRUWKH<HDU(QGLQJ0DUFK ফা਋৴੥঵ౚ੒୳ హஊ৬ସનয়म౥വ‫؛‬హஊఁপप਱ऐગ਺ৱ॑ಲਢघॊ‫ ؛‬ ফা਋ ফা਋ ౐ਜ਼‫૸؟‬৞ ৐ফૻ ૟અ ‫ق‬ৰౚ‫ك‬ ‫ق‬੒୳‫ك‬ ਲ਼঱ৈ ৐ফૻ٫ੜ॑ৰਠ ४ख़ঀ঑ॡ५হ঵ ٫ ॹঝॱ४ख़থ‫ؚ‬ਭ౏੾঵ਘ৲ ೷௭ਭିଋ৐ফૻद৺੏ੜ‫ؚ‬ &52হ঵ ٫ ॺঞথॻ॑೐੅ఁপघॊ ੔ഈୢ௜হ঵ ٫ ী৕୰৶হ঵ఁপपିৡ ୰৶൧૵হ঵ ٫ ঽഞ఼਄+39ਫ਼ਪমત৫઩ ᮏ♫䞉㐃⤖ㄪᩚ ‫ٻ‬ ‫ٻ‬ ੾঵ા৷ ઽஇৡఁপपૢगथଢ଼஢৫৅ ‫ق‬ଢ଼஢৫৅ા‫ك‬

14. Slide 14: Consolidated Business Forecast and Medium-Term Vision

    &RQVROLGDWHG%XVLQHVV)RUHFDVWIRUWKH<HDU(QGLQJ0DUFK র਋ऊফ৽੾ੑ઺ਈીফ২प਱ऐथ ¾ ਲ਼঱ଡਛ୷౮‫ق‬੔ഈୢ௜হ঵ਲ਼঱ऋੑ઺ૻপ்੖‫ك‬ऋ‫ؚ‬ਹஇ୷౮भਉ౤ ¾ ਹஇ୷౮म৸৬ਲ਼঱भ঱ஷो఺ल੔ഈୢ௜হ঵৖भ੾঵ਘ৲पेॉর਋৓पੰ଎ ¾ ফা਋ା৉॑ৄथৗૠরশ਋ੑ઺॑ੁ৒੒৒ হ঵શਲ਼঱ ‫ٳ‬৴੥ਲ਼঱ৈੑ઺ ੏৞ ‫ٳ‬৴੥੾঵ਹஇੑ઺ ੏৞‫پ‬র਋৽੾9LVLRQ ‫ق‬੏৞‫ك‬ ੑ઺ ৰౚ ੑ઺ ৰౚ ੑ઺ ੒୳ ৴੥ਲ਼঱ৈੑ઺ ৴੥੾঵ਹஇੑ઺ ‫ق‬੏৞‫ك‬ ४ख़ঀ঑ॡ५হ঵ ੒୳ ৴੥ਲ਼঱ৈৰౚ ৴੥੾঵ਹஇৰౚ

15. Slide 15: Business topics

    ⋝হ঵ॺআॵॡ५ Copyright© TransGenic Inc. All Rights Reserved. 15

16. Slide 16: Business Topics: Drug discovery support platform

    %XVLQHVV7RSLFV হ঵ॺআॵॡ५‫؟‬,%/धभৱম઀௚॑ৢगञ਄ਬঢ়બ 7* *ॢ ॢঝ‫ش‬উभ໮஋औोञৰౚ ॢঝ উ ໮஋औोञৰౚ ౚ धૼ ౚध ૼ୒ঀक़ঁक़पेॊ௬੼௺‫ؚ‬,%/ ૼ୒ঀक़ क़पेॊ௬੼௺‫ ؚ‬%/भ໮஋औोञৰౚधஆঽ ໮஋औोञৰ ञৰ ৰౚ भಿ৬੿ଲૼ୒॑੆়औच‫ؚ‬ঋথॳক‫ش‬੫঵भથ৷३‫ش‬६भહਸ੼க॑ৈीॊ ॊ ੦ຊଢ଼஢ ൉ఇ੍ର ੫঵‫ڼ‬ ർด੦ຊଢ଼஢ ଢ଼஢஢ ৵৿੟पेॊ ৵৿੟पेॊ ेॊ প৿੟प প৿੟पेॊ पे पेॊ ॊ ಏ෫૥ୡ ୡ ൧ ૵ ൉ఇଢ଼஢ ஢ శಏ෫૥ୡ ୡ శಏ෫૥ୡ ୡ Drug disco

17. Slide 17: Business Topics: Delta Gene business

    %XVLQHVV7RSLFV হ঵ॺআॵॡ५‫'؟‬HOWDJHQঐक़५भ৸਼ੀदभஆಚ୹ஔ 7* *঺ঔॹঝঐक़५হ঵भೲ঱ऑ‫٭‬৸਼ੀषभ୿ਲ਼ன৫ ৫ ৺௺ଁभঔॹঝঐक़५ ਀ਠ஑ॹ‫ॱش‬ঋ‫ش‬५ ৺௺ଁभঔॹঝঐक़५ ୰ଙ૭ଳ৲ঐक़५ಉ ॹঝॱ४ख़থ঺मਊ঺भ఩஫৕୊ശঐक़५भ੿ଲ‫୹؞‬ஔચৡ॑ણ৷‫ؚ‬ਊ঺मॹঝ ॱ४ख़থ঺भ਼ੀ৓୿ਲ਼ි॑ણ৷खঔॹঝঐक़५୿ਲ਼ఁপ॑௕ॊ‫؛‬ Copyright© TransGenic Inc. All Rights Reserved. 17

18. Slide 18: Business Topics: Business development for drug discovery support

    %XVLQHVV7RSLFV হ঵ॺআॵॡ५‫؟‬ੴ৓ଃਓਥঅ४ॿ५भ૾ய఺लਤன ਊ঺ऋથघॊੴ৓ଃਓਥभઽஇ৲म఻ਠ৲खणणँॊ‫؛‬০৏मॢঝ‫ش‬উใோহ঵भ ઽஇৡਘ৲॑੦पੴ৓ଃਓਥभન৳‫؞‬ણ৷‫؞‬଑ল॑ਸசऔचॊ‫؛‬ ൧૵ఇ ൧૵ఇও‫ش‬ढ़‫ش‬ ൧૵ఇ୿ਲ਼ ੴ৓ଃਓਥभઽஇඃ੭भॖও‫ش‬४ ४ ‫پ‬ಏ෫૥ୡ‫ؚ‬ଲષ ৲ಉभ৫৅ଢ଼஢ ॢট‫ش‬ংঝঊঝ५ॣ॔ ႌরऋ॒ঐ‫ش‬ढ़‫ؚش‬ ੫঵‫ق‬৪ব‫ؚك‬ዥႠ ᷈ऋ॒ঐ‫ش‬ढ़‫ؚش‬ ৫৅ 0(',঺‫ق‬রব‫ؚك‬൧ ᆌႌஓऋ॒ঐ‫ش‬ढ़‫ش‬HWF ૵ఇও‫ش‬ढ़‫قش‬঩ম‫ ك‬ ൧૵ఇ৫৅ ൧૵ఇ

19. Slide 19: Business Topics: M&A and cash flow

    %XVLQHVV7RSLFV হ঵ॺআॵॡ५‫؟‬ৱস৹୸఺लऒोऽदभਛশਅറ ৘ৃ৹୸ৱস॑ણ৷खহ঵੦ೕଡണभ౥വ‫ؚ‬0 $पेॊਛশਸச॑ৰਠ ऒोऽदभ৹୸ৱসभઞಥ఺लजभ஍ટ ऒो ोऽदभ ोऽदभ৹୸ৱসभઞಥ఺लजभ஍ટ भ৹୸ ટ ਲ਼঱ৈ f৹୸ৱসम੕પ৺੏௲ਐ৞ ‫ق‬ৱসઞಥ‫ك‬ 2,500 ‹ হ঵੦ೕਘ৲भञीઋૺଢ଼஢ਚ਋༠भ૦ਝ 2,250 ‹ &52হ঵भৗૠ৫઩‫ؚ‬఩஫৕ੰෲহ঵େઽ 2,000 1,750 1,500 ੒ ‫ء‬ ‹ হ঵ఁপ‫؞‬ଓਘ॑৯৓धखञৗఇজ१‫ॳش‬७থॱ‫ؚش‬ ४ख़ॿॸॕॵॡ‫؞‬ছ঎भॢঝ‫ش‬উ৲ ‫ش‬ 1,

20. Slide 20: R&D pipeline

    ⋞ଢ଼஢৫৅૾ய Copyright© TransGenic Inc. All Rights Reserved. 20

21. Slide 21: Overview of Research & Development Pipeline

    2YHUYLHZRI5HVHDUFK 'HYHORSPHQW3LSHOLQH ৫৅ঃॖউছॖথ૾ய‫؟‬ঔॹঝঐक़५௺ଁ ఩஫৕੝૗ૼ୒৫৅ 526$ౠਜ਼दभੌఌइ 7*঺ ৰ৷৲ੋ &5,635&DV১ 7*঺ ৰ৷৲ੋ ঔॹঝঐक़५௺ଁभ৫৅ ঽ঺ऽञमਗ৖ଢ଼஢ਃঢ়ऊैभ଑ো৫৅ ৺ফ ৺ফ ॱ‫ش‬।ॵॺ ਀ਠ஑ ঔॹঝ ୿ਲ਼ .2RU7J धखथभ ఩஫৕ ੰෲ ਫ਼઒ &52 ৵ཝ৬५ॺঞ५૭ଳ৲ঐक़५ ৶ଢ଼ ୿ਲ਼র ෷৲५ॺঞ५૭ଳ৲ঐक़५ ණ஝প ୿ਲ਼র ༇ඪ૭ଳ৲ঐक़५ ණ஝প ୿ਲ਼র ໚ऋ॒ঔॹঝঐक़५ ృପপ ୿ਲ਼র ఽ஑ঔॹঝঐक़५ ਓ੕ଢ଼ ୿ਲ਼র ෝ௥೪਑ঔॹঝঐक़५ 7

22. Slide 22: Overview of Research & Development Pipeline

    2YHUYLHZRI5HVHDUFK 'HYHORSPHQW3LSHOLQH ৫৅ঃॖউছॖথ૾ய‫؟‬ಿ৬‫؞‬൧૵ఇ ৺ফ ৺ফ‫ع‬ ॱ‫ش‬।ॵॺ ಿ৬ થ৷ਙ ೾৒௺ ছॖ७থ५ ॔क़ॺ ঱৘ ৊৒ ੿ଲ ਫ਼઒ ଡണ ಏ෫৫৅ ಢ ಿ৬ଲષभ৫৅धૢ৷ ਗ৖ଢ଼஢ਃঢ়ऊैभ଑ো৫৅ ਋ ঱৘प਱ऐਤষর ႌরऋ॒ঐ‫ش‬ढ़‫ش‬ ృପপ৾ಉ ব৔൧૵ఇও‫ش‬ढ़‫كش‬ ‫پ‬রব੫঵दभಏ෫૥ୡৰ઱র ছॖ७থ५੔ઐ௱র বয় ୯ਸॹ‫ॱش‬໮஋র ᷈ऋ॒ঐ‫ش‬ढ़‫ش‬ ऋ॒७থॱ‫قپش‬ઙ‫ك‬ඊႵে੟ଢ଼஢ਚधુ৊ଢ଼஢ ೾৒य़ॵॺ୿ਲ਼র ‫پ‬রব੫঵धஆಚছॖ७থ५ీ৺ഁ੥

23. Slide 23: Topics of Research & Development

    7RSLFVRI5HVHDUFK 'HYHORSPHQW ফ২ଢ଼஢৫৅૾ய ‫ڰ‬া ৗૠঔॹঝঐक़५௺ଁ ༇ඪ૭ଳ৲‫ؚ‬໚ऋ॒‫ؚ‬ෝ௥೪਑ঔॹঝঐक़५ ୿ਲ਼৫઩ ।ঀ঒ౣૐૼ୒ &5,635&DV पశஆಚছॖ७থ५ీ৺॑%URDG,QVWLWXWHधഁ੥ ংॖड़ই॓‫ش‬ঐ४কঃথपঈ‫ش‬५লன া ୢ৲৾൉ఇઙૄভ঺धभಿ৬ୢఇ३‫ش‬६पঢ়घॊુ৊ଢ଼஢ీ৺ഁ੥ ਸ਼৚঩মৰୡ৿੟৾ভ੕ভपथছথॳঙথ७঑ॼ‫ش‬৫ಈ া َටஓ঄ॺ৲ঐक़५ُपঢ়घॊব੠્ಅ॑লൢ 75(&.३५ॸ঒ਭ౏‫ؚ‬ଲષ୿ਲ਼৫઩ ਸ਼৚঩ম໚ቅ৾ভ৾୒੕ভলன ీ৺ঢ়৴ ્ಅ ଲષ‫؞‬१‫ش‬অ५ ৾ভ

24. Slide 24: Topics of Research & Development

    7RSLFVRI5HVHDUFK 'HYHORSPHQW ফ২ଢ଼஢৫৅૾ய া ॔ॺআ‫ش‬ਙຜჹ༇ঔॹঝঐक़५पঢ়घॊஆಚছॖ७থ५ీ৺॑ௗಛୢఐপ৾धഁ੥ া ੳੴඪঔॹঝঐक़५पঢ়घॊஆಚৰ઱ಅဍీ৺॑થ଒ভ঺ষ৿ୢఐ৾ଢ଼஢ਚधഁ੥ ਸ਼৚ব੠ᙥ໚థ।ঀ঒ভ৮पঈ‫ش‬५লன ୰ଙ‫ق‬৵ཝ৬५ॺঞ५‫ؚ‬෷৲५ॺঞ५‫ك‬૭ଳ৲ঐक़५भ૛ધऋِ಍ཝّपൕൗ ୰ଙ‫ق‬༇ඪ‫ك‬૭ଳ৲ঐक़५भ૛ધऋِ6FLHQWLILF5HSRUWVّपൕൗ া ിমপ৾఺लୢ৲৾൉ఇઙૄভ঺धभৗૠ৐য়Ꮳऋ॒ঐ‫ش‬ढ़‫ش‬पঢ়घॊુ৊ଢ଼஢ీ৺ഁ੥ ॢট‫ش‬ংঝঊঝ५ॣ॔੫঵धभ*$13œঐक़५ૼ୒प

25. Slide 25: Our Intellectual Property

    2XU,QWHOOHFWXDO3URSHUW\ ਌ਏऩ્ಅभਛয়૾ய ِ$8ّड़‫ش‬५ॺছজ॔पथਛয় ফা ِ86ّ৪বपथਛয় ফা ِ(3ّ௎ପपथਛয় ফা ِ=/ّরবपथਛয় ফা ॺছॵউঐक़५ૼ୒ ِ+.%ّಘ௃पथਛয় ফা ِ-3ّ঩মपथਛয় ফা ِ=/ّরবपथਛয় ফা ِ86ّ৪বपथਛয় ফা ঄ॺ৲ঐक़५ ِ-3ّ঩মपथਛয় ফা ටஓ঄ॺ৲ঐक़५ ِ-3ّ঩মपथਛয় ফা ِ=/ّরবपथਛয় ফা ِ$8ّड़‫ش‬५ॺছজ॔पथਛয় ফা ِ(3ّ௎ପपथਛয় ফা ِ-3ّ঩মपथਛয় ফা ‫œۅۃڶڼ‬ঐक़५ૼ୒ ِ.5ّ஻বपथਛয় ফা ِ

26. Slide 26: Appendix

    ⋟ॺআॵॡ५ Copyright© TransGenic Inc. All Rights Reserved. 26

27. Slide 27: Technical Expertise

    7HFKQLFDO([SHUWLVH ৬ਗ൧૵ఇ‫؟‬ຩऋ॒‫ق‬$EERWW/DERUDWRULHV‫ك‬ ຩऋ॒೩঻भഷরद౮ଞऩউটॺটথঅথऋ঱ಊघॊऒधऋਾઔऔोञ /LHEPDQHWDO1(QJO-0HG )XML\DPDHWDO+HSDWRJDVWURHQWHURORJ\ 0DUUHURHWDO+HSDWRORJ\ ਫଞຩ಍ཝ ຩऋ॒಍ཝ SURWKURPELQ‫ق‬ഷัᅼಕਸ਼,,౤৕‫ك‬ SURWKURPELQ‫ق‬ഷัᅼಕਸ਼,,౤৕‫ك‬ JJOXWDP\OFDUER[\ODVH JJOXWDP\OFDUER[\ODVH FDUER[\ODWLRQRI*OX *OD SUR

28. Slide 28: Technical Expertise

    7HFKQLFDO([SHUWLVH ஆಚ୿ਲ਼ీ৺‫ॹ؟‬ঝॱ४ख़থ঺ঀॵॡ॔क़ॺঐक़५ ৪বॹঝॱ४ख़থ঺ ফা঩ 5HSRVLWRU\DQG6HUYLFH$JUHHPHQW॑ഁ੥‫؛‬ 'HOWDJHQ঺ঀॵॡ॔क़ॺঐक़५௺ଁघसथभ৳ଵ ध৸਼ੀषभ઀୹॑৫઩‫؛‬ Copyright© TransGenic Inc. All Rights Reserved. 28

29. Slide 29: Technical Expertise

    7HFKQLFDO([SHUWLVH ൉ఇपउऐॊঀॵॡ॔क़ॺঐक़५भਜ਼઼હऐ ।ঀ঒൉ఇमଷ૷‫؟‬ ¾ ఩஫৕ଡୗटऐदमਃચमਂ৥ ¾ ਃચੰෲऊै५ॱ‫ॺش‬घॊभदกপऩ॥५ॺऋ૑ਏ ঀॵॡ॔क़ॺঐक़५म‫ء‬ ¾ ௺ଁ౴য়टऐदमਂેী ¾ ਀ਠ஑ੰෲऋ૑ਏ ¾ ਀ਠ஑ੰෲपमกপऩ॥५ॺऋऊऊॊ ੿ଲ॥५ॺभ৺ ೅ ॺ ৺ ਀ਠ஑ੰෲॹ‫ॱش‬ऋँोय‫ؚ‬ ¾ ൉ఇॱ‫ش‬।ॵॺ౜ଓभ৭৒पથ৷ ¾ ఇදभ஍ટਖ਼৒पुਹ৷૭ચ Copyright© TransGenic Inc. All Rights Reserved. 29

30. Slide 30: Technical Expertise

    7HFKQLFDO([SHUWLVH ॹঝॱ४ख़থ঺पणःथ ¾ ফप൉঵ ¾ (6಍ཝ॑৷ःञৼ৊ੌఌइपेॊঀॵॡ॔क़ॺঐक़५੿ଲ॑ পૠெपষअૼ୒॑৫৅ ¾ n'UXJJDEOHJHQRPH ൉ఇॱ‫ش‬।ॵॺधऩॉअॊ।ঀ঒‫|ك‬ ॑ॱ‫ش‬।ॵॺधघॊ‫؛‬ ¾ ੭ैोञঀॵॡ॔क़ॺঐक़५भ਀ਠ஑॑३५ॸঐॸॕॵॡप ੰෲघॊ্১॑નয় Copyright© TransGenic Inc. All Rights Reserved. 30

31. Slide 31: Delta One and Delta Base

    7HFKQLFDO([SHUWLVH ਏ৺‫ॹ؟‬ঝॱ४ख़থ঺भঀॵॡ॔क़ॺঐक़५ • ൉ఇॱ‫ش‬।ॵॺभ఩஫৕पইज़‫ش‬ढ़५खञ௺ଁਰ঱भ ౴য়ੋाঀॵॡ॔क़ॺঐक़५‫؟‬ 'HOWD2QH70 • ऒभअठ௺ଁपणःथभ਀ਠ஑ॹ‫ॱش‬ঋ‫ش‬५‫؟‬ 'HOWD%DVH70 • శஆಚছॖ७থ५ీ৺पेॉ‫ؚ‬৸਼ੀदभెਢ৓ઞ৷॑ಅဍ • ૹ঵৓ऩୢఇષ৫৅ଢ଼஢पઞ৷૭ Copyright© TransGenic Inc. All Rights Reserved. 31

32. Slide 32: Technical Expertise

    7HFKQLFDO([SHUWLVH ્ඉ‫؟ڭ‬n'UXJJDEOHJHQRPH| ൉ఇॱ‫ش‬।ॵॺधऩॉअॊଡୗ‫ؚ‬ਃચऋ੒୳औोॊ఩஫৕॑ॱ‫ش‬।ॵॺधघॊ‫؛‬ )DPLO\ 1RRI 7DUJHWV *ॱথঃॡુ૽஑ঞ७উॱ‫* ش‬3&5 ॳকথॿঝ‫&ق‬KDQQHO ॱথঃॡସীੰᇪಞ‫ق‬3URWHDVH‫ك‬ ॺছথ५এ‫قشॱش‬7UDQVSRUWHU‫ك‬ জথ෷৲ᇪಞ‫ق‬.LQDVH‫ك‬ ൓জথ෷৲ᇪಞ 3KRVSKDWDVH ॱথঃॡସীੰ৽ଡ଼‫ق‬3URWHLQ'HJUDGDWLRQ3DWKZD\ ॱথঃॡସীੰᇪಞ༛૩ী৕‫ق‬3URWHDVH,QKL

33. Slide 33: Technical Expertise

    7HFKQLFDO([SHUWLVH ્ඉ‫਀؟ڮ‬ਠ஑ੰෲॹ‫ॱش‬ ষ৿ੰෲ ಏ෫ਚৄध୰৶ੰෲ ಏ෫ਚৄध୰৶ੰෲ • अण૾ଙ ഠ৲ • ஄ଙ৾৓ੰෲ • ஄ଙ৾৓ੰෲ • ਂ਍ • ੰღ৾৓ੰෲ • ੰღ৾৓ੰෲ • ઈ৿ • ഷัਫ਼ਪ • ഷัਫ਼ਪ • ൱ಁ • ে৲৾ਫ਼ਪ • ে৲৾ਫ਼ਪ • ઈ৿ੈ৹ਙ • ੌ௶৾৓ੰෲ • ੌ௶৾৓ੰෲ • ലಁખೝ (PEU\ R াೡ ఩஫৕৅ਠ ᶦਙ‫ؚ‬লে৐ • /DF=ഉ౦ ৏भಱଈਙ • 573&5 ཯ਙ Copyright© TransGenic Inc. All Rights Reserved. 33

34. Slide 34: Technical Expertise

    7HFKQLFDO([SHUWLVHŃ ୻‫਀؟‬ਠ஑ੰෲऊै൉ఇॱ‫ش‬।ॵॺ౜ଓ఩஫৕भർด ૘৕ৈೡ৲‫؟‬෗ႈ೩ऋੜਸ ෗दਃચघॊ఩஫৕॑ॱ‫ش‬।ॵॺपघॊ ৬੎ J ৬শ FP ఩஫৕ ॖड़থॳকথॿঝ‫ڶ‬ ৙ে஑ ‫ۄۀ‬ ৙ে஑ ‫ۄۀ‬ ๢෗ ৙ে஑ ‫ۄۀ‬ ଍೐෗ੜ༢ऋৄैोॊপ৶લ୰஘भ਀ਠ஑ Copyright© TransGenic Inc. All Rights Reserved. 34

35. Slide 35: Technical Expertise

    7HFKQLFDO([SHUWLVHŃ ୻‫਀؟‬ਠ஑ੰෲऊै੭ैोॊ൉ఇॱ‫ش‬।ॵॺ౜ଓ఩஫৕ েણಆຯ୰म॥থॺট‫ش‬ঝ૭ચ‫؟‬ઋ৽‫؞‬ಖઋႈ೩पା৯ തཋ‫ਂؚ‬਍भੲ৿‫ؚ‬ർดষ৿प੎ਏदँॊधઅइैोथःॊ‫ؚ‬প౼ຜସ‫ؚ‬ਲ஝‫ؚ‬ ⑻࿝৬द৅ਠघॊ఩஫৕॑৭උ /DF=৅ਠ ౼৸৬ 2SHQILHOGWHVW ৎ৑ ఩஫৕ ZKROHPRXQW ‫ॱڼ‬থঃॡସુ૽ਭઍ৬ ‫*ق‬3&5 % ৙ে஑ ‫ۄۀ‬ রੱ৖दૌओघৎ৑ऋ੖ॊ ਂ਍૎भੜপ॑ંྮ ౼જൺ Copyright© TransGenic Inc. All Rights Reserved. 35

36. Slide 36: Cell count

    7HFKQLFDO([SHUWLVHŃ ୻‫਀؟‬ਠ஑ੰෲऊै੭ैोॊ൉ఇॱ‫ش‬।ॵॺ౜ଓ఩஫৕ ৉ૉ୭୆भப৲‫؟‬ຜჹႈ೩ऋੜਸ ຜჹඪ૾ऋলॊঀॵॡ॔क़ॺঐक़५॑৭උ ຜჹ୰৶൸ জথঃත୰৶൸ ഷর஀রૉ ৙ে஑ .2 ৙ে஑ .2 &HOOFRXQW ৙ে஑ ‫ۄۀ‬ ஀রૉभ࿠ဋ জথঃ᫨ཝभ଎ଷ ஀রૉੜਸ ࿫ᆅྐ༇‫ق‬ຜৣ࿫ᆅभ༇ඪ‫ك‬ ඊႵਂ৸॑ંྮ ඊႵਂ৸ ࿫ᆅྐ༇ ఩஫৕ ൓জথ෷৲ᇪಞ& Copyright© TransGenic Inc. All Rights Reserved. 36

37. Slide 37: TG Resource Bank and Delta One

    7HFKQLFDO([SHUWLVHŃ ॺছথ५४ख़ॽॵॡ঺भ઀୹घॊঀॵॡ॔क़ॺঐक़५ ঀॵॡ॔क़ॺঐक़५ 7*5HVRXUFH%DQNⰍ 'HOWD2QH70 ੿ଲਭ౏ পૠெ‫ිؚ‬ၨ৓‫ؚ‬ছথ ൉ఇॱ‫ش‬।ॵॺधखथ ఏ৓఩஫৕ ओൌ஦भ఩஫৕ ॲ঒प୊ശऔोञ఩஫ થ৷ਙऋৈः఩஫৕ ৕‫ق‬৺఩஫৕‫ك‬ ‫ق‬৺఩஫৕‫ك‬ ৼ৊ੌఌइ১‫ؚ‬ ૭૗஑఩஫৕ॺছॵউ ੿ଲ্১ ৼ৊ੌఌइ১ &5,635&DV১ ১ ঐक़५भವ਋ ‫ڳ‬ধা‫ع‬ ‫گ‬ধা ‫گ‬ধা घसथभਥਹमൂ౅঻ ઀୹஄ଙ ઞ৷ਥಅဍ ઞ৷ਥಅဍ पషര ા৷ ਐ৞‫ع‬ ਐ৞‫ع‬ 86ॻঝ‫ع

38. Slide 38: http://www.transgenic.co.jp

    䡚ே䚻䛾೺ᗣ䛸㇏䛛䛺ᬽ䜙䛧䛾䛯䜑䛻䡚 http://www.transgenic.co.jp

Trans Genic Group — FY2015 Earnings Presentation on 6ix